Inspection Readiness: What 2025 Has Taught Us

In today’s life sciences landscape, inspection readiness isn’t a one-time event, it’s a continuous state of operational clarity. As regulatory expectations evolve, companies must move beyond reactive prep and embrace systems that make quality the default.

A recent article from The FDA Group emphasizes that “the most successful companies don’t really ‘prepare’ for FDA inspections—they operate in a constant state of readiness.” This means pristine documentation, trained personnel, and workflows that reflect real-time operations, not just compliance on paper.

And the stakes are rising. According to Hogan Lovells, FDA warning letters in 2025 have already surpassed last year’s totals, with a sharper focus on systemic compliance gaps. The agency is shifting toward ongoing oversight, issuing follow-up inspections and untitled letters even when Form 483 responses are deemed adequate. Inspectors are now evaluating not only the content of documentation but also its format, flagging inconsistencies in headers, versioning, and metadata as signs of poor control.

What Does Inspection Readiness Look Like in Practice?

1. Documentation Must Tell a Coherent Story

Your documentation should be self-explanatory, traceable, and aligned with your quality narrative.

• Enhance review and approval processes by including someone not directly involved with the product to assess clarity and completeness.
• Increase traceability not just between requirements, specifications, and test protocols, but also across validation plans, deviations, and CAPAs.
• Apply ALCOA+ principles to ensure data integrity: documentation must be attributable, legible, contemporaneous, original, accurate, complete, consistent, enduring, and available.
• Standardize formatting using a Document Management System (DMS) that enforces templates, version control, and metadata fields. This helps prevent audit findings related to inconsistent headers, missing approval dates, or unclear revision histories.

2. Personnel Must Be Inspection-Ready, Not Just Trained

Inspectors assess not just what your team does, but how confidently and clearly they explain it.

• Conduct mock interviews with Subject Matter Experts (SMEs) to build fluency in regulatory context.
• Use AI-powered tools like Microsoft PowerPoint’s Rehearse with Coach, Yoodli, or Speeko to simulate inspection scenarios and provide real-time feedback on clarity, pacing, and tone.
• Train staff on inspection roles including ready room support, inspection host, and IT backup personnel.
• Empower operators to explain not just their tasks, but the rationale behind them, using data and scientific reasoning.

3. Systems Must Be Modular, Scalable, and Audit-Ready by Design

Inspection readiness should be embedded into daily operations, not reserved for audit season.

• Conduct regular internal audits and use metrics to track readiness trends.
• Designate a war room and back room setup to manage inspection flow and document retrieval.
• Include suppliers in your readiness program by auditing third-party documentation and integrating quality agreements into your QMS.
• Use integrated digital systems, such as MES, QMS, and DMS platforms, that communicate seamlessly to ensure that deviations, validations, and documentation updates are reflected in real time. While larger companies often rely on multiple disconnected systems, smaller organizations can benefit from all-in-one platforms built with integration at their core. These solutions reduce manual handoffs, improve traceability, and make inspection readiness a natural outcome of daily operations.

At Sakara Digital, we believe inspection readiness is a reflection of operational integrity. It’s not about perfection, it’s about building workflows that speak for themselves.

Further reading from industry leaders:

The FDA Group – How to Prepare for an FDA Inspection

Hogan Lovells – FDA Medical Device Inspections in 2025

AVS Life Sciences Best Practices for Regulatory Inspection Readiness in the Biotech, Pharmaceutical, and Medical Device Industries

Leucine – The Complete Guide to FDA Inspection Readiness in 2025

This article was created in collaboration with GenAI and shaped by intentional human insight.

#FractionalConsulting #InspectionReadiness #Pharma #Biotech #MedicalDevices

Amie Harpe Founder and Principal Consultant

Amie Harpe is a strategic consultant, IT leader, and founder of Sakara Digital, with 20+ years of experience delivering global quality, compliance, and digital transformation initiatives across pharma, biotech, medical device, and consumer health. She specializes in GxP compliance, AI governance and adoption, document management systems (including Veeva QMS), program management, and operational optimization — with a proven track record of leading complex, high-impact initiatives (often with budgets exceeding $40M) and managing cross-functional, multicultural teams. Through Sakara Digital, Amie helps organizations navigate digital transformation with clarity, flexibility, and purpose, delivering senior-level fractional consulting directly to clients and through strategic partnerships with consulting firms and software providers. She currently serves as Strategic Partner to IntuitionLabs on GxP compliance and AI-enabled transformation for pharmaceutical and life sciences clients. Amie is also the founder of Peacefully Proven (peacefullyproven.com), a wellness brand focused on intentional, peaceful living.

See Full Bio